CTNNB1 and Hand-foot syndrome: In summary, quercetin, kaempferol, β-sitosterol, and stigmasterol are the active components of SPSCG, which can target AKT1, CASP3, CCND1, CTNNB1, and EGFR to exert anti-inflammatory and antioxidative effects for treating HFS.